LOw DosE Spironolactone, chlorThAlidone oR Combination in CKD Trial
LOw DosE Spironolactone, chlorThAlidone oR Combination in CKD Trial
Not yet recruiting · NCT07645300 · Registry updated 2026-06-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| LOw DosE Spironolactone, chlorThAlidone oR Combination in CKD Trial | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, cardiovascular disorder, chronic renal failure syndrome, hypertensive disorder, kidney disorder, kidney failure, urinary system disorder, vascular disorder | Not yet recruiting | Phase 2 | 2026-06-12 | NCT07645300 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Michael E. DeBakey VA Medical Center | 13 |
| VA Office of Research and Development | 472 |
| VA Salt Lake City Health Care System | 5 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Richard L. Roudebush VA Medical Center, Indianapolis, IN | Indianapolis | United States | 16 |